Home Massive interference in free T4 and free T3 assays misleading clinical judgment
Article
Licensed
Unlicensed Requires Authentication

Massive interference in free T4 and free T3 assays misleading clinical judgment

  • Julien Favresse , Henry Paridaens , Nathalie Pirson , Dominique Maiter and Damien Gruson EMAIL logo
Published/Copyright: September 26, 2016

Received: 2016-3-30
Accepted: 2016-8-22
Published Online: 2016-9-26
Published in Print: 2017-3-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. The central role of external quality assurance in harmonisation and standardisation for laboratory medicine
  4. Review
  5. Fecal calprotectin in inflammatory bowel diseases: update and perspectives
  6. Mini Review
  7. Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation
  8. Opinion Papers
  9. Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE)
  10. Metabolite profiling can change health-care delivery to obese patients with fatty liver disease: the search for biomarkers
  11. Genetics and Molecular Diagnostics
  12. Rapid screening for targeted genetic variants via high-resolution melting curve analysis
  13. Evaluation of the new cobas® HCV genotyping test based on real-time PCRs of three different HCV genome regions
  14. General Clinical Chemistry and Laboratory Medicine
  15. Harmonisation of serum dihydrotestosterone analysis: establishment of an external quality assurance program
  16. Spanish Preanalytical Quality Monitoring Program (SEQC), an overview of 12 years’ experience
  17. Peer groups splitting in Croatian EQA scheme: a trade-off between homogeneity and sample size number
  18. Prevalence of pseudonatremia in a clinical laboratory – role of the water content
  19. Retrospective validation of a β-trace protein interpretation algorithm for the diagnosis of cerebrospinal fluid leakage
  20. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective
  21. Performance evaluation of ImmunoCAP® ISAC 112: a multi-site study
  22. Clinical autoantibody detection by microarray
  23. Cardiovascular Diseases
  24. Kinetics of troponin I in patients with myocardial injury after noncardiac surgery
  25. Infectious Diseases
  26. P35 and P22 Toxoplasma gondii antigens abbreviate regions to diagnose acquired toxoplasmosis during pregnancy: toward single-sample assays
  27. Letters to the Editor
  28. Deciphering a macro-troponin I complex; a case report
  29. Interference of laboratory disinfection with trichloro-isocyanuric acid on cardiac troponin I measurement using the Vitros immunoassay system
  30. Massive interference in free T4 and free T3 assays misleading clinical judgment
  31. In defense of aldosterone measurement by immunoassay: a broader perspective
  32. The prevalence of hemolysis – a survey using hemolysis index
  33. Detection of BRAFV600K mutant tumor-derived DNA in the pleural effusion from a patient with metastatic melanoma
  34. Evaluation of the accuracy of the Greiner Bio-One FC Mix Glucose tube
  35. Congress Abstracts
  36. 4th EFLM-BD European Conference on Preanalytical Phase Amsterdam (NL), 24–25 March 2017
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2016-0255/html
Scroll to top button